240 240 correctly predicted forecasts
Send me real-time posts from this site at my email
Chris Lau

Are You Buying Valeant Pharmaceuticals?
16 may

$VRX was a short-sell call call for DIYers in 2015. The stock topped $248 on July, 2015.

Coverage resumed for the Value Stock investor last year and continues. VRX bottomed in the $12-15 range. 

Irina Koffler finally came to her senses and upgraded the stock to a hold. Her record on https://www.tipranks.com/ is here:

Are you buying Valeant stock? 

Agree for YES.

Disagree for NO.

Are You Buying Valeant Pharmaceuticals?

Untill the end of voting

37 people answered this forecast.

Would you like to know how many people agreed or disagreed? Vote.